PlainRecalls
FDA Drug Moderate Class II Ongoing

Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25

Reported: June 25, 2025 Initiated: May 29, 2025 #D-0472-2025

Product Description

Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25

Reason for Recall

Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.

Details

Recalling Firm
Eugia US LLC
Units Affected
48,000 vials
Distribution
Nationwide in the USA
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25. Recalled by Eugia US LLC. Units affected: 48,000 vials.
Why was this product recalled?
Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 25, 2025. Severity: Moderate. Recall number: D-0472-2025.